Impilo acquires VaccinDirekt – the leading Nordic retail vaccination provider
VaccinDirekt is the leading Nordic vaccination provider in a winning channel enjoying strong underlying growth, primarily driven by increased public awareness for vaccines, the enhanced focus on preventive healthcare, and a steadily growing pipeline of new vaccines. The Company is well positioned to extend its leadership, leveraging its unparalleled quality, know-how, and customer focus, coupled with a large physical footprint in central locations, offering superior convenience and availability to its growing base of more than 1.4 million registered customers.
Read moreNews
Impilo’s portfolio company Decon acquires Acekare – a French-based manufacturer and distributor of mobility assistance solutions
The acquisition of Acekare marks an important step in Decon’s strategic ambition to build a leading European niche mobility platform by adding a complementary product company to its existing offering and establishing a direct presence in the French market
Impilo’s portfolio company Pelago Bioscience acquires RG Discovery, forming an integrated drug discovery partner spanning biology and chemistry
Impilo’s portfolio company Pelago Bioscience acquires RG Discovery, forming an integrated drug discovery partner spanning biology and chemistry
Impilo completes the acquisition of Oticon Medical
We are pleased to announce that Impilo has today completed the acquisition of Oticon Medical from Demant A/S. This marks the first investment in our recently raised Fund II.